[1]吴 鹏,杨 喜,高 尚,等.基于网络药理学、分子对接研究肉苁蓉-淫羊藿-骨碎补治疗骨质疏松的作用机制[J].医学信息,2024,37(13):1-6.[doi:10.3969/j.issn.1006-1959.2024.13.001]
 Mechanism of Herba Cistanches-Epimedium Herb-Fortunes Drynaria Rhizome in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.Mechanism of Herba Cistanches-Epimedium Herb-Fortune’s Drynaria Rhizome in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking[J].Journal of Medical Information,2024,37(13):1-6.[doi:10.3969/j.issn.1006-1959.2024.13.001]
点击复制

基于网络药理学、分子对接研究肉苁蓉-淫羊藿-骨碎补治疗骨质疏松的作用机制()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年13期
页码:
1-6
栏目:
出版日期:
2024-07-01

文章信息/Info

Title:
Mechanism of Herba Cistanches-Epimedium Herb-Fortune’s Drynaria Rhizome in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking
文章编号:
1006-1959(2024)13-0001-06
作者:
吴 鹏杨 喜高 尚
(1.内蒙古医科大学基础医学院,内蒙古 呼和浩特 010000;2.内蒙古医科大学第二附属医院影像科,内蒙古 呼和浩特 010000)
Author(s):
Mechanism of Herba Cistanches-Epimedium Herb-Fortune’s Drynaria Rhizome in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking
(1.School of Basic Medicine,Inner Mongolia Medical University,Hohhot 010000,Inner Mongolia,China;2.Department of Imaging,the Second Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010000,Inner Mongolia,China)
关键词:
肉苁蓉淫羊藿骨碎补网络药理学分子对接作用机制
Keywords:
Herba cistanchesEpimedium herbFortune’s drynaria rhizomeNetwork pharmacologyMolecular dockingMechanism of action
分类号:
R683
DOI:
10.3969/j.issn.1006-1959.2024.13.001
文献标志码:
A
摘要:
目的 采用网络药理学方法研究肉苁蓉-淫羊藿-骨碎补对骨质疏松的作用机制。方法 采用中药系统药理学数据库与分析平台(TCMSP)查找肉苁蓉-淫羊藿-骨碎补主要成分及靶点,采用Geen Cards数据库查找骨质疏松的靶基因。应用Venny2.1.0取基因交集,采用String数据库进行蛋白互作网络分析,Cytoscape构建活性-成分-靶点网络图,David数据库进行GO富集分析和KEGG通路分析,并进行分子对接。结果 肉苁蓉-淫羊藿-骨碎补有效成分46种,与骨质疏松共同的靶点有225个,有效成分中suchilactone、quercetin、luteolin、kaempferol、eriodictyol、eriodyctiol、naringenin为核心成分,AKT1、ERS2、MMP-9、AR、mTOR为核心靶点;GO富集显示得到489个生物学过程(BP)、53个细胞组成(CC)、100个分子功能(MF)。KEGG结果显示得到癌症通路、PI3K-Akt信号通路、雌激素信号通路等149条。分子对接结果显示MMP-9与suchilactone、quercetin、luteolin、kaempferol能较好地结合。结论 肉苁蓉-淫羊藿-骨碎补作用于骨质疏松是多靶点的,药物有效成分能从多途径调控骨质疏松相关靶标,治疗骨质疏松。
Abstract:
Objective To study the mechanism of herba cistanches-epimedium herb-fortune’s drynaria rhizome on osteoporosis by network pharmacology.Methods Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was used to find the main components and targets of herba cistanches-epimedium herb-fortune’s drynaria rhizome, and Geen Cards database was used to find the target genes of osteoporosis. Venny2.1.0 was used to take gene intersection, String database was used for protein interaction network analysis, Cytoscape was used to construct activity-component-target network diagram, David database was used for GO enrichment analysis and KEGG pathway analysis, and molecular docking was carried out.Results There were 46 effective components in herba cistanches-epimedium herb-fortune’s drynaria rhizome, and 225 common targets with osteoporosis. suchilactone, quercetin, luteolin, kaempferol, eriodictyol, eriodyctiol and naringenin were the core components, AKT1, ERS2, MMP-9, AR and mTOR were the core targets. GO enrichment showed 489 biological processes (BP), 53 cellular components (CC) and 100 molecular functions (MF). The results of KEGG showed that 149 cancer pathways, PI3K-Akt signaling pathways, estrogen signaling pathways and so on were obtained. The results of molecular docking showed that MMP-9 could bind to suchilactone, quercetin, luteolin and kaempferol well.Conclusion Herba cistanches-epimedium herb-fortune’s drynaria rhizome has a multi-target effect on osteoporosis. The effective components of the drug can regulate osteoporosis-related targets from multiple pathways to treat osteoporosis.

参考文献/References:

[1]胡思婧,练晨霞,张奇,等.熟地黄的大麻素2型受体激动剂活性及对骨代谢的调控作用研究[J].中草药,2022,53(20):6481-6491.[2]Wu D,Cline-Smith A,Shashkova E,et al.T-Cell Mediated Inflammation in Postmenopausal Osteoporosis[J].Front Immunol,2021,12:687551.[3]马江涛,万雷,黄宏兴.基于网络药理学探讨骨碎补治疗骨质疏松症的作用机制[J].中国骨质疏松杂志,2020,26(4):490-496.[4]杨雯静,黄健,王维,等.基于网络药理学和体外细胞实验探究“三七-骨碎补”药对活性成分治疗骨质疏松症的作用机制[J].中国中药杂志,2023,48(4):1087-1097.[5]Bi Z,Zhang W,Yan X.Anti-inflammatory and immunoregulatory effects of icariin and icaritin[J].Biomed Pharmacother,2022,151:113180.[6]Dai Z.Study on the Protective Effect and Mechanism of the Rhizoma Drynariae-Epimedium Formula on Osteoarthritis in Rats[J].Contrast Media Mol Imaging,2022,2022:2869707.[7]Zhao JF,Xu JY,Xu YE,et al.High-Throughput Metabolomics Method for Discovering Metabolic Biomarkers and Pathways to Reveal Effects and Molecular Mechanism of Ethanol Extract From Epimedium Against Osteoporosis[J].Front Pharmacol,2020,11:1318.[8]Li M,Zhang ND,Wang Y,et al.Coordinate regulatory osteogenesis effects of icariin, timosaponin B II and ferulic acid from traditional Chinese medicine formulas on UMR-106 osteoblastic cells and osteoblasts in neonatal rat calvaria cultures[J].J Ethnopharmacol,2016,185:120-131.[9]冯朵,王靖,蒋勇军,等.肉苁蓉总苷对HepG2细胞增殖、凋亡及Wnt/β-Catenin通路相关蛋白表达的影响[J].食品工业科技,2023,44(20):389-397.[10]Wang F,Tu P,Zeng K,et al.Total glycosides and polysaccharides of Cistanche deserticola prevent osteoporosis by activating Wnt/β-catenin signaling pathway in SAMP6 mice[J].J Ethnopharmacol,2021,271:113899.[11]Ma X,Zhu X,He X,et al.The Wnt pathway regulator expression levels and their relationship to bone metabolism in thoracolumbar osteoporotic vertebral compression fracture patients[J].Am J Transl Res,2021,13(5):4812-4818.[12]Xiao L,Zhong M,Huang Y,et al.Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways[J].Aging (Albany NY),2020,12(21):21706-21729.[13]Abdurahman A,Li X,Li J,et al.Loading-driven PI3K/Akt signaling and erythropoiesis enhanced angiogenesis and osteogenesis in a postmenopausal osteoporosis mouse model[J].Bone,2022,157:116346.[14]Han J,Li L,Zhang C,et al.Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway[J].Front Pharmacol,2022,12:772944.[15]Verma A,Aggarwal K,Agrawal R,et al.Molecular mechanisms regulating the pharmacological actions of icariin with special focus on PI3K-AKT and Nrf-2 signaling pathways[J].Mol Biol Rep,2022,49(9):9023-9032.[16]Sabry M,Mostafa S,Rashed L,et al.Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats[J].PLoS One,2021,16(2):e0244650.[17]Liu YY,Ding YF,Sui HJ,et al.Pilose antler (Cervus elaphus Linnaeus) polysaccharide and polypeptide extract inhibits bone resorption in high turnover type osteoporosis by stimulating the MAKP and MMP-9 signaling pathways[J].J Ethnopharmacol,2023,304:116052.[18]Vakili S,Zal F,Mostafavi-Pour Z,et al.Quercetin and vitamin E alleviate ovariectomy-induced osteoporosis by modulating autophagy and apoptosis in rat bone cells[J].J Cell Physiol,2021,236(5):3495-3509.[19]Liang G,Zhao J,Dou Y,et al.Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology[J].Front Endocrinol (Lausanne),2022,13:866641.

相似文献/References:

[1]于向鹏,马春梅,马旭东,等.大黄和肉苁蓉水煎液对家兔离体小肠运动影响的研究[J].医学信息,2021,34(06):97.[doi:10.3969/j.issn.1006-1959.2021.06.025]
 YU Xiang-peng,MA Chun-mei,MA Xu-dong,et al.Effect of Decoction of Rhubarb and Cistanche on the Movement of Isolated Small Intestine of Rabbits[J].Journal of Medical Information,2021,34(13):97.[doi:10.3969/j.issn.1006-1959.2021.06.025]
[2]蒋 俊,毛国庆.生信分析肾阳虚型绝经后骨质疏松症分子机制及淫羊藿的靶向治疗机制[J].医学信息,2023,36(04):21.[doi:10.3969/j.issn.1006-1959.2023.04.004]
 JIANG Jun,MAO Guo-qing.Bioinformatics Analysis of the Molecular Mechanism of Postmenopausal Osteoporosis with Kidney-yang Deficiency and the Targeted Treatment Mechanism of Epimedium Herb[J].Journal of Medical Information,2023,36(13):21.[doi:10.3969/j.issn.1006-1959.2023.04.004]
[3]陈 沫,郝 娟,王涵斌,等.参葛补肾胶囊中淫羊藿的薄层色谱鉴别研究[J].医学信息,2025,38(07):141.[doi:10.3969/j.issn.1006-1959.2025.07.028]
 CHEN Mo,HAO Juan,WANG Hanbin,et al.Study on Thin Layer Chromatography Identification of Epimedium brevicornu Maxim. in Shenge Bushen Capsule[J].Journal of Medical Information,2025,38(13):141.[doi:10.3969/j.issn.1006-1959.2025.07.028]

更新日期/Last Update: 1900-01-01